Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet's Uveitis: Customizing Therapy according to the Clinical Features.
Ocul Immunol Inflamm
; 30(2): 506-514, 2022 Feb 17.
Article
in En
| MEDLINE
| ID: mdl-33021421
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uveitis
/
Behcet Syndrome
Type of study:
Diagnostic_studies
/
Observational_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Ocul Immunol Inflamm
Journal subject:
ALERGIA E IMUNOLOGIA
/
OFTALMOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Italia
Country of publication:
Reino Unido